New SEC Form D filing

Moonwalk Biosciences, Inc., 2026-09-14

A new SEC Form D private-offering notice from South San Francisco, CA, a $70,249,973 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Moonwalk Biosciences, Inc. site↗ Verified via SEC Form D

Biotech company developing adipose-targeted RNA (siRNA) therapies for cardiometabolic diseases, including obesity.

Filed 4 days agoFiled to raise $70,249,973First money in 2026-08-26Raised so far $59,999,998HQ (as filed) South San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified moonwalk.bio↗Named in the filing 8 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source